-
Oct 22, 2013, 13:00
by
Michael Croft
Clinical Informatics News Brief | CureCancerStarter.org launched today, serving as a crowdfunding platform connecting cancer patients, their friends and family to cancer researchers.
Full story
-
Oct 21, 2013, 13:00
by
Michael Croft
Economic Times of India | The Economic Times of India reports that the Indian Supreme Court has ruled that all clinical trials in the country must be for the benefit of the Indian population and not "multinational companies." 157 trials already approved have been halted; five trials were approved to carry on.
Full story
-
Oct 21, 2013, 07:00
by
Michael Croft
Boston Globe | Ariad Pharmaceuticals abruptly terminated a clinical trial for a leukemia drug on Friday, after early trial data from 150 sites suggested safety issues such as blood clots, strokes, and heart attacks.
Full story
-
Oct 18, 2013, 10:15
by
Michael Croft
Clinical Informatics News | The National Quality Forum's ongoing effort to endorse qualified performance measures based on patient-reported outcomes highlights the challenges to developing validated measurement tools - and the slow pace of our health care system in adopting them.
Full story
-
Oct 17, 2013, 12:00
by
Michael Croft
Clinical Informatics News Brief | Quintiles and the Muscular Dystrophy Association (MDA) announced a new partnership last week to develop and implement the U.S. Neuromuscular Disease Registry, a patient registry that will play an important role in determining effective treatments for people with muscular dystrophy and related muscle diseases.
Full story
-
Oct 17, 2013, 11:00
by
Michael Croft
VentureBeat | Veeva Systems, a software-as-a-service company that focuses on the life sciences industry, had its IPO this week, proving a SaaS model can see great returns in life sciences.
Full story
-
Oct 17, 2013, 09:00
by
Michael Croft
Clinical Informatics News | The health care system has learned to ask patients more about their physical health, but Alexandra Drane of Eliza Corporation wants to know what we can find out if we ask patients about deeper personal challenges in their lives.
Full story
-
Oct 16, 2013, 10:00
by
Michael Croft
Clinical Informatics News | “At our heart we are a technology company,” Eric Silberstein says, “but we are technologists who have a very deep appreciation for and understanding of clinical trials. We basically believe that clinical trials are some of the most important things that take places in this world.”
Full story
-
Oct 15, 2013, 08:55
by
Michael Croft
Clinical Informatics News | Dr. Judith Hibbard and her colleagues have found a single measure that correlates with healthy lifestyles, preventive medical behaviors, positive health profiles, fewer hospitalizations, effective self-management and lower health care costs. And the best news is, with a little effort from hospitals, clinics and providers, anyone can be moved up the scale.
Full story
-
Oct 14, 2013, 08:30
by
Michael Croft
The Lancet Oncology | A team of British researchers has released an estimate of the total cost of cancer to the 27 countries in the European Union, taking into account both direct healthcare costs and indirect productivity losses to the economy.
Full story
-
Oct 14, 2013, 06:00
by
Michael Croft
Clinical Informatics News | Vanderbilt University’s PREDICT program is putting genomes to work in the clinic, using drug-gene interaction data to suggest the right drugs for cardiology patients. The biggest challenge, though, might lie in predicting people’s behavior.
Full story
-
Oct 11, 2013, 12:00
by
Michael Croft
Fox Video | GlaxoSmithKline CEO Andrew Witty speaks with Fox about GSK's committment to publishing all clinical trial reports, and how the data will improve the industry.
Full story
-
Oct 11, 2013, 08:00
by
Michael Croft
Clinical Informatics News | Failure is a known risk during any clinical trial, particularly since later stage failures can cost tens of millions of dollars in addition to valuable resources that could be redirected for other product development. The Tufts Center for the Study of Drug Development (CSDD) researched reasons for failure in an effort to help drug developers quantify the reasons.
Full story
-
Oct 10, 2013, 15:00
by
Michael Croft
RAND Corporation | According to a recent study, physicians report more professional satisfaction when they perceive the quality of patient care in their practices to be high.
Full story
-
Oct 10, 2013, 07:00
by
Michael Croft
New York Times | Critically ill patients are still being enrolled in National Institutes of Health trials since the government shutdown, but the pace has slowed drastically.
Full story
-
Oct 9, 2013, 10:00
by
Michael Croft
Barcelona Digital Technology Center | A European collaborative this week released the first prototype of a home IT tool for seniors, to promote their health, security, and social participation.
Full story
-
Oct 8, 2013, 15:15
by
Michael Croft
Clinical Informatics News | Two large-scale surveys, the Coriell Personalized Medicine Collaborative and the Impact of Personal Genomics Study, have have been peering into consumer responses to genomic test results. Now they're delivering insights into the mindsets and health behaviors of patients who seek out whole genome sequencing.
Full story
-
Oct 8, 2013, 13:00
by
Michael Croft
InformationWeek | Big data can transform clinical trials. At least that's the gamble Merck is making with its partnership with Maccabi, the second largest health organization in Israel, to use their data for clinical trials.
Full story
-
Oct 4, 2013, 07:00
by
Michael Croft
Clinical Informatics News | Many changes are in play that impact drug development strategies: growth of global markets, increasing age of population, and the associated cost pressure of chronic diseases such as obesity, cardiovascular disease, hypertension and diabetes. The Affordable Care Act provides a new set of cost pressures by expansion of coverage, development of new health insurance markets, controlling cost and improving quality of health care delivery.
Full story
-
Oct 2, 2013, 12:00
by
Michael Croft
CNN | New patient registrations for NIH-funded clinical trials are on hold due to the government shutdown. Six new studies slated to start this week have been put on hold.
Full story